[FATE] YoY Annual Result on 31-Dec-2021 [#FY]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
28-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#FY]
Profit Trend
YoY- -21.14%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 63,533 96,300 55,846 31,434 10,680 4,740 4,106 57.82%
PBT -160,928 -281,721 -212,151 -173,387 -98,149 -66,598 -42,952 24.61%
Tax 0 -26,665 -5,850 -3,087 -441 2,190 297 -
NP -160,928 -255,056 -206,301 -170,300 -97,708 -66,598 -42,952 24.61%
Tax Rate - - - - - - - -
Total Cost 224,461 351,356 262,147 201,734 108,388 71,338 47,058 29.72%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -253.30 -264.86 -369.41 -541.77 -914.87 -1,405.02 -1,046.08 -21.04%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.64 -2.63 -2.18 -2.07 -1.43 -1.19 -1.02 8.23%
EPS Diluted -1.64 -2.63 -2.18 -2.07 -1.43 -1.19 -1.02 8.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.